Provisions and Profit

Provisions and Profit

Korea Asset In Trust's FY2025 recovery is largely an accounting rearrangement. Reported net income rose to ₩49.4bn and the return measure management leads with swung 16 percentage points, but total loss-absorbing provisions rose 3.6%, substandard-and-below assets fell 7%, and ₩254m was written off against a ₩63.7bn credit charge. The dividend was funded from share premium, not earnings.

What FY2025's profit is made of

Consolidated operating revenue fell 9.8% to ₩204.3bn and operating income fell 33.9% to ₩34.2bn, yet net income rose 32.0% to ₩49.4bn [1]. The bridge between those two directions is one line. Non-operating income was ₩32.6bn against ₩1.0bn a year earlier, and ₩26.7bn of it sits in a single "other" row [2]. The note's only explanation is a one-line footnote: the row includes ₩26.6bn of judgment principal, interest and legal costs from litigation the company won [3]. No case, counterparty or appeal status is disclosed anywhere in the filing.

Sources: FY2025 Annual Business Report, consolidated statement of comprehensive income [4] and Note 25 [5].

The litigation item does at least appear to be cash. It was not reversed as a non-cash adjustment in the indirect cash-flow reconciliation — only ₩17.7m of non-operating income was — and consolidated other receivables rose ₩5.6bn over the year [6], against operating cash flow of ₩203.3bn [7]. It is not recurring: ₩26.7bn equals 78% of the year's operating income, and no pipeline of similar claims is disclosed.

The allowance and the reserve

The measure management puts forward as the year's real result is a separate-basis adjusted return on equity of 9.51%, against reported consolidated ROE of 4.64% [8]. The definition sits on the same page: net income plus the reversal of the regulatory credit-loss reserve (or minus its appropriation), divided by average equity from which that same reserve has been deducted. The reserve therefore lifts the numerator and shrinks the denominator in a year it is released, and does the reverse in a year it is built.

That reserve is not a profit-and-loss item. Under the Financial Investment Business Regulation the company must appropriate out of retained earnings whatever amount its IFRS allowance falls short of the supervisory minimum [9]. It is the gap between two provisioning standards, not a second layer of protection on top of the first. When the IFRS allowance rises, the required reserve falls by roughly the same amount, and the pot of money standing against bad assets barely moves.

That is what happened. Between end-FY2024 and end-FY2025 the IFRS allowance rose ₩63.8bn, from ₩151.9bn to ₩215.7bn, while the regulatory reserve fell ₩52.2bn, from ₩169.8bn to ₩117.6bn. Total provisions rose ₩11.6bn, or 3.6% [10]. The swap repeated in the first quarter of 2026: allowance up ₩27.0bn, reserve down ₩18.1bn, total up ₩8.9bn [11].

Sources: FY2022 Annual Business Report, asset soundness status [12]; FY2025 Annual Business Report, asset soundness status [13]; 1Q 2026 investor presentation [14].

Because the reserve movement drives the adjusted profit figure, that figure swings far harder than the business does. Reported consolidated net income has ranged between ₩37.4bn and ₩129.6bn over five years; the reserve-adjusted number has ranged between minus ₩46.4bn and plus ₩119.6bn. In FY2024 the group appropriated ₩83.8bn to the reserve and posted an adjusted loss; in FY2025 it reversed ₩52.2bn of that and posted adjusted profit of ₩101.6bn — its highest in three years, on the lowest operating income in the series.

Sources: credit-loss reserve notes — FY2022 Annual Business Report [15], FY2023 [16], FY2024 [17], FY2025 [18].

Summed across the five years, reported net income is ₩432.2bn and reserve-adjusted profit is ₩336.2bn. The ₩96.0bn difference is the net amount the reserve grew over the period, from ₩21.6bn at end-2020 [19] to ₩117.6bn at end-2025 — the cumulative shortfall of IFRS provisioning against the supervisory formula. As a five-year series, the adjusted return averages about 5.4% across FY2021–FY2025: 13.01%, 9.57%, 1.35%, minus 6.55%, 9.51% [20] [21]. For a business whose collateral is a property cycle, the multi-year average is the more useful anchor, and it sits close to what the one broker still covering the stock assumes: a September 2025 note values the shares at 0.35 times forward book on an implied 5.1% return on equity, and no research has been published on the company since [22].

What the underlying sites did

The classification data says the sites themselves barely moved. Assets classified substandard or below fell from ₩763.0bn to ₩707.9bn — down 7.2% — and still account for 49% of all assets subject to classification, against 31% two years earlier [23]. At 31 March 2026 the substandard-and-below balance was ₩711bn, marginally above the year-end figure, though the normal-grade balance rose 14% in the quarter [24].

Source: 1Q 2026 investor presentation, asset quality condition [25].

Underneath the totals, one thing did change materially, and it cuts in the company's favour. Loan receivables assessed individually for impairment — the credit-impaired population — rose from ₩147.5bn to ₩416.8bn, a 2.8-fold increase, with the substandard grade's individually assessed balance standing at ₩285.0bn against ₩45.6bn a year earlier [26] [27]. Individual assessment discounts each site's own expected recovery rather than applying a portfolio loss rate, and it is the stricter treatment. The allowance rate on the trust-account loan book followed: 13.16% at end-FY2024, 20.09% at end-FY2025 [28], and 25.28% at 31 March 2026 [29].

Provisions against write-offs

An allowance is an estimate until something is written off. Over three years the group charged ₩174.3bn of credit losses against loan receivables and wrote off ₩19.4bn — 11% of what it provided. FY2025 is the extreme case: a ₩63.7bn charge and ₩254m of write-offs, a ratio of 0.4% [30].

Two other lines point the same way. Interest recognised on assets already deemed credit-impaired — booked into income but drawn out of the allowance rather than collected — rose from ₩0.6bn in FY2023 to ₩1.6bn and then ₩3.3bn [31]. And group-wide, interest received in cash has run below interest recognised for three consecutive years — by ₩32.4bn, ₩11.6bn and ₩16.0bn, ₩60.0bn cumulatively [32] [33]. The filings do not split how much of that gap is interest capitalised into trust-account balances rather than genuinely uncollected, so the gap bounds the question without settling it.

Sources: FY2025 Annual Business Report, movement in allowance for credit losses on loan receivables [34] consolidated statement of cash flows [35] and consolidated statement of comprehensive income [36]; write-off percentages derived.

The auditor has named the same estimate a key audit matter in each of the last three years — expected credit loss on loan receivables, alongside occurrence and period attribution of land-trust fees — while issuing an unqualified opinion each time [37]. The following page records that the engagement passes from Han Young to Samjong for FY2026 to FY2028 under the periodic-designation rule [38]. A new firm inheriting a three-year-old key audit matter is a dated, checkable event; its first full-year opinion lands in March 2027.

What paid the dividend

The FY2025 dividend rose 50% to ₩150 per share, or ₩18.4bn, against separate-basis net income of ₩25.4bn — a payout ratio of 72.26%, the second consecutive year above 70% [39].

The same page shows where the money came from, and the company states it directly. Two entries fed distributable retained earnings during the year that had nothing to do with trading: a ₩60.0bn transfer of share premium into retained earnings [40], and a ₩45.3bn release of the credit-loss reserve appropriated a year earlier. The footnote to the appropriation statement says the cash dividend is to be paid out of that transferred capital reserve, under Article 461-2 of the Commercial Act [41]. The mechanism is ordinary and lawful in Korea, and the ₩60bn sat inside shareholders' equity before the transfer as it does after. What it means for a reader is that the dividend increase carries no information about earning power, and that both additions to distributable profit were one-time.

Where the evidence lands

The read here is that FY2025's improvement is mostly presentation. Operating income fell by a third; the profit increase came from a litigation award; the return measure improved because a reserve was released rather than because sites recovered; and the dividend was funded from share premium. On the underlying asset question the year was roughly neutral to modestly better — a 7% reduction in substandard-and-below balances and a genuinely stricter allowance basis, but with almost nothing written off to test either.

The strongest fact against that read sits in the first quarter of 2026. The trust-account loan book fell from ₩802.6bn to ₩739.4bn, and the cash-flow reconciliation shows ₩63.2bn of net recovery from it in three months [42] [43] — the first period in this corpus where the book returned cash at scale rather than absorbing it. Recoveries sustained at that pace would settle the recoverability question faster than any provisioning debate.

Against that, the credit charge has not eased. Management wrote in March 2026 that because expected losses on major sites had already been conservatively reflected across 2024 and 2025, the additional credit-cost burden should ease gradually [44]. The quarter that followed carried a ₩32.3bn charge, 3.6 times the year-ago quarter and above every quarter of 2025 [45]. The fourth quarter of 2025, inside the year that produced the 9.51% figure, was itself an operating loss of ₩5.6bn and a net loss of ₩5.2bn [46].

Sources: quarterly investor presentations, operating expense detail — 1Q 2025 [47], 2Q 2025 [48], 3Q 2025 [49], FY2025 [50], 1Q 2026 [51].

Three observable things would move this read. If substandard-and-below balances fall materially below ₩600bn while the trust-account allowance rate holds near 25%, provisioning is being validated by outcomes rather than reshuffled. If write-offs return to double-digit billions without the classified balance falling, the FY2025 allowance was too thin. And if the regulatory reserve keeps unwinding while total provisions stay flat, the adjusted return will keep improving with nothing underneath it changing. Each is disclosed quarterly, in the asset-soundness table and the allowance schedule.

The multiple the market has already applied to that record is taken up in Price Against Book. The dated chronicle of how the company arrived here is in History; the mechanics of the loan book itself are in Business.